Yarrow Bioscience, Inc. YARW
13.60 USD -1.31 (-8.79%)
At closeNov 5, 2026, 5:09 PM EST
12.80 -0.80 -5.88%
After hours · Nov 5, 5:09 PM ET
12.39 Day range 16.05
12.39 52-week range 46.95
- YTD
- -53.10%
- 1 year
- -19.53%
- Market cap
- 126.54M
- YTD return
- -53.10%
- 1-year return
- -19.53%
- Volume
- 319.97K
- Avg volume
- 125.22K
- Open
- 15.50
- Previous close
- 14.91
- Day's range
- 12.39 – 16.05
- 52-week range
- 12.39 – 46.95
30m -6.40 (-32.00%)
Financials — quick view
YARW Revenue — quarterly 97.00K
YARW Net income — quarterly -3.01M
YARW EPS — quarterly -3.51
News
Yarrow Bioscience Announces Participation in November Investor Events 
Contrasting Yarrow Bioscience (NASDAQ:YARW) and Atara Biotherapeutics (NASDAQ:ATRA) 
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares 
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering 
Yarrow Bioscience Launches Underwritten Public Offering To Fund Pipeline Development And Corporate Operations; No Terms Disclosed 
Yarrow Bioscience Announces Proposed Underwritten Public Offering 
Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate 
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update 
This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday 
BTIG Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $58
Your note
Sign in to keep a note on YARW — it syncs with the Stock Master app.